Emrise Corp. (EMRI) 1.1100 $EMRI EMRISE CORPORATION

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Emrise Corp. (EMRI) 1.1100 $EMRI

EMRISE CORPORATION Reduces Size of Board of Directors; Provides Update on Plan of Dissolution
GlobeNewswire - Wed May 18, 8:39AM CDT
EMRISE CORPORATION (formerly traded on OTCQB under the symbol EMRI) (EMRISE or the Company), announced today that the Company, as planned, has reduced the size of its Board of Directors from three Directors to one with the resignations of Julie A. Abraham and Otis W. Baskin, effective, May 17, 2016. Frank P. Russomanno will remain on the Board and continue to serve as the Executive Director of the Company.

EMRISE CORPORATION Announces Second Liquidation Distribution to Stockholders
GlobeNewswire - Tue Apr 19, 7:45AM CDT
EMRISE CORPORATION (formerly traded on OTCQB under the symbol EMRI) (EMRISE or the Company), announced today that it has instructed its paying agent, VStock Transfer, LLC (Paying Agent), to begin the process of sending the previously announced second liquidation distribution of $0.36 per share (the Distribution) to its stockholders of record as of the close of business on July 7, 2015.

EMRISE CORPORATION Announces Date and Amount of Second Liquidation Distribution to Stockholders
GlobeNewswire - Tue Mar 15, 8:48AM CDT
EMRISE CORPORATION (formerly traded on OTCQB under the symbol EMRI) (EMRISE or the Company), today announced that the Company expects to make a second liquidation distribution to its stockholders in the amount of $0.36 per share (approximately $3.9 million in the aggregate) during the week of April 19, 2016 (the Distribution). Stockholders of record as of the close of business on July 7, 2015 will be entitled to receive the Distribution.

EMRISE CORPORATION Signs Letter of Intent to Sell CXR-Anderson Jacobson in France
GlobeNewswire - Mon Dec 28, 7:45AM CST
EMRISE CORPORATION (formerly traded on OTCQB under the symbol EMRI) ("EMRISE" or the "Company", today announced that it has signed a Letter of Intent to sell all of the issued and outstanding stock of CXR Anderson Jacobson S.A.S. based in France ("CXR-AJ" to Carmine T. and Georgeann Oliva or an entity that would be wholly owned by them (the "Purchaser". Oliva is the former Chairman and CEO of EMRISE Corporation, and he was also the President of CXR-AJ.

EMRISE Revises Record Date to July 7, 2015
GlobeNewswire - Wed Dec 09, 12:05PM CST
EMRISE CORPORATION (formerly traded on OTCQB under the symbol EMRI) ("EMRISE" or the "Company", today announced that it has revised the previously announced record date for its initial liquidating distribution in the amount of $0.75 per share of common stock from July 1, 2015 to July 7, 2015. The effective date for payment of the distribution on December 1, 2015 remains unchanged.

EMRISE Corporation Provides Additional Update on Status of Previously Announced Plan of Dissolution
GlobeNewswire - Mon Nov 16, 7:45AM CST
EMRISE CORPORATION (formerly traded on OTCQB under the symbol EMRI) ("EMRISE" or the "Company", today provided its stockholders with an additional update on the status of its previously announced voluntary Plan of Dissolution (the "Plan" that was approved by its stockholders at a special meeting of stockholders held on June 25, 2015.

Behrman Capital Completes $515 Million Recapitalization for DDC
PR Newswire - Mon Jul 20, 7:11AM CDT
Behrman Capital, a private equity investment firm based in New York and San Francisco, today announced that it has completed a $515 million recapitalization for Data Device Corporation (DDC), a leader in high-reliability connectivity, power, and control solutions for aerospace, defense, and industrial applications. Since acquiring DDC, Behrman Capital and management have created value through a number of successful strategic initiatives, including the acquisitions of Emrise Electronics and National Hybrid Inc as well as the spin-off of ILC Dover.

Behrman Capital Portfolio Company DDC Acquires Emrise Electronics Ltd.
PR Newswire - Tue Jun 30, 12:06PM CDT
Behrman Capital, a private equity investment firm based in New York and San Francisco, today announced that its portfolio company Data Device Corporation (DDC), a leader in high reliability connectivity, power, and control solutions, has acquired Emrise Corporation's (OTCQB: EMRI) electronic devices group, Emrise Electronics Ltd. Emrise Electronics is comprised of XCEL Power Systems Ltd and Pascall Electronics Ltd, which are international market leaders in high reliability power conversion products.

EMRISE Corporation Closes Transaction to Sell Its Electronic Devices Business to Data Device Corporation
GlobeNewswire - Tue Jun 30, 11:16AM CDT
EMRISE CORPORATION (OTCQB:EMRI) ("EMRISE" or the "Company", today announced that it has completed the sale of its electronic devices business unit, which constitutes the sale of substantially all of its assets (the "Transaction", to an affiliate of Data Device Corporation ("DDC". The Company entered into a stock purchase agreement dated March 22, 2015 (the "Purchase Agreement" to sell its electronic devices business unit to DDC, subject to various closing conditions, including stockholder approval. At a special meeting of its stockholders held on June 25, 2015 (the "Special Meeting", stockholders approved the Transaction.

EMRISE Announces 2015 First Quarter Results
GlobeNewswire - Fri May 15, 3:56PM CDT
EMRISE CORPORATION (OTCQB:EMRI), ("EMRISE" or the "Company" a multi-national manufacturer of defense and aerospace electronic devices and communications equipment, today announced its financial results for the first quarter ended March 31, 2015.

Penny Stocks Buzz for Emrise, First Choice Healthcare Solutions, TapImmune, Veriteq, CANYON COPPER, and MaryJane
PR Newswire - Wed May 13, 7:45AM CDT
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: Emrise (OTCMKTS:EMRI), First Choice Healthcare Solutions (OTCMKTS:FCHS), TapImmune (OTCMKTS:TPIV), Veriteq (OTCMKTS:VTEQ), CANYON COPPER (OTCMKTS:CNYCF), and MaryJane (OTCMKTS:MJMJ).

EMRISE Corporation Announces Special Meeting of Stockholders to Approve Sale of Substantially All of Its Assets, a Plan of Liquidation and Dissolution and Related Matters
GlobeNewswire - Mon May 11, 7:45AM CDT
Mails Definitive Proxy Statement and Proxy Card to Stockholders

EMRISE Announces 2014 Fourth Quarter and Year-End Results
GlobeNewswire - Tue Mar 31, 10:30AM CDT
EMRISE CORPORATION (OTCQB:EMRI) ("EMRISE" or the "Company", a multi-national manufacturer of defense and aerospace electronic devices and communications equipment, today announced its financial results for the fourth quarter and year ended December 31, 2014.

EMRISE Corporation Announces Agreement to Sell Its Electronic Devices Business Unit to Data Device Corporation
GlobeNewswire - Mon Mar 23, 7:45AM CDT
EMRISE CORPORATION (OTCQB:EMRI), a multi-national manufacturer of defense and aerospace electronic devices and communications equipment ("Emrise" or the "Company", today announced that it has entered into a stock purchase agreement (the "Purchase Agreement" with an affiliate of Data Device Corporation ("DDC" to sell all of the issued and outstanding shares of the common stock of the Company's wholly owned subsidiary, EMRISE Electronics Ltd. ("EEL", for a cash purchase price of $22 million, net of debt, transaction and other related expenses and a holdback of $1.3 million in escrow to secure indemnification obligations and any shortfall in working capital (the "Transaction". This is expected to yield net proceeds of approximately $11 million to the Company, excluding amounts held in escrow and after payment of certain taxes and liquidation related expenses. The Transaction has been unanimously approved by the Company's Board of Directors and is subject to stockholder approval.

EMRISE Receives $8.4 Million Order for Electronic Device Subsystems for In-Flight Entertainment and Connectivity (IFE&C) Systems
GlobeNewswire - Tue Jan 20, 7:45AM CST
EMRISE CORPORATION (OTCQB:EMRI), a multi-national manufacturer of defense and aerospace electronic devices and communications equipment, today announced that it has received an $8.4 million production order for electronic device subsystems for In-Flight Entertainment and Connectivity (IFE&C) systems to be installed in commercial aircraft.

EMRISE Announces 2014 Third Quarter, Nine-Month Results
GlobeNewswire - Fri Nov 14, 7:45AM CST
EMRISE CORPORATION (OTCQB:EMRI), ("EMRISE" or the "Company" a multi-national manufacturer of defense and aerospace electronic devices and communications equipment, today announced its financial results for the third quarter and nine months ended September 30, 2014.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 10

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 8

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 12

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 11

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 9

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 11

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 14

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 15

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Mercury Capital Secures $4.35M Loan for Retail Hub

Updated Category News Views 21

Mercury Capital Partners Banks on Retail Development They say the beauty's in the numbers, but the magic happens when you make those numbers work for you. Mercury Capital Partners (MCP) is wrangling dollars like no one's business, pushing a $4.35 million construction loan into the Fort Myers scene like it's a walk in the park. We're looking at Estero Oaks, a...

Continue Reading
Amazon Analysts Update Forecasts for Upcoming Earnings Report

Updated Category News Views 130

Amazon's Upcoming Earnings Call Amazon.com, Inc. (NASDAQ: AMZN) is set to unveil its earnings results for the second quarter. This announcement will provide valuable insights into the company's financial health and operational performance. Market expectations are leaning toward a positive outlook, as analysts predict robust earnings and revenue growth. Predicted Earnings...

Continue Reading
Understanding the Recent Surge in ServiceNow Options Activity

Updated Category News Views 82

Understanding the Recent Surge in ServiceNow Options Activity Recently, a notable shift occurred in the options market surrounding ServiceNow (NYSE: NOW), drawing attention from both institutional and retail investors. With deep pockets behind these moves, it's crucial to analyze what it could mean for the future of the stock. It’s always intriguing when a significant...

Continue Reading
Join the Exciting Bybit Boost Battle for Weekly USDT Prizes!

Updated Category News Views 176

Join the Exciting Bybit Boost Battle for Weekly USDT Prizes! Bybit, recognized as the second-largest cryptocurrency exchange globally by trading volume, has initiated a vibrant competition called the Boost Battle. This thrilling event allows traders to participate weekly, showcasing their skills and strategies. The grand prize rolls out weekly, presenting winners with the...

Continue Reading
Desert Control's Q2 Progress: Innovations and Financial Insights

Updated Category News Views 190

Desert Control's Q2 2025 Report Summary Desert Control AS (DSRT) has made commendable strides in the second quarter of 2025, revealing significant operational achievements and promising financial results. This report encapsulates the journey and progress of the company, focusing on their innovative solutions that enhance soil health and water conservation. Operational...

Continue Reading